The Glucose Meter Market size is expected to reach USD 21.27 Billion in 2030 and register a revenue CAGR of 9.5% over the forecast period, according to latest report by Reports and Data.
The Glucose Meter Market size is expected to reach USD 21.27 Billion in 2030 and register a revenue CAGR of 9.5% over the forecast period, according to latest report by Reports and Data. Increase in diabetes population across the globe and rise in awareness about diabetes preventive care are key factors driving market revenue growth. According to the World Health Organization (WHO), diabetes is a major cause of blindness, kidney failure, heart attack, stroke, and lower limb amputation. WHO further states that the prevalence of diabetes is rising more rapidly in low and middle-income countries.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/95
Rising incidence of diabetes and obesity is posing a serious threat to the global healthcare system, and the need for proper screening of diabetes is becoming more important with increase in global geriatric population who are more prone to diabetes. Moreover, according to the International Diabetes Federation (IDF), one in two (50.1%) people leaving with diabetics do not know that they have diabetes. Furthermore, it estimates that the global prevalence of impaired glucose tolerance will increase from 7.5% in 2019 to 8.0% by 2030 and will reach 8.6% by 2045. Therefore, proper screening of diabetes is of utmost importance, along with increase in awareness about diabetes and diabetes prevention. In May 2021, for instance, the World Health Assembly agreed a resolution on strengthening prevention and control of diabetes. Such initiatives are expected to increase awareness about diabetes and regular monitoring of blood glucose levels, which is expected to drive revenue growth of the global glucose meter market during the forecast period.
Growing awareness and need for prevention and care of diabetes are leading to increase in screening and monitoring of blood glucose levels, which in turn, is increasing demand for glucose meters. Technological advancements in the healthcare sector, and innovative and more accurate and affordable products launched by key players are generating lucrative growth opportunities. This is resulting in increase in demand for self-monitoring blood glucose systems, as well as continuous glucose monitoring systems, which are effective and reliable devices for monitoring blood glucose levels in both hypoglycemic and hyperglycemic patients. Self-monitoring systems are suitable for diabetic patients of middle and low-income countries, owing to their availability and comparatively low costs. Continuous glucose monitoring systems help diabetic patients by providing real-time data on glucose levels via sensors and transmitters, which can be connected and shared with the help of digital devices or applications. This minimally invasive procedure is of immense help to monitor blood glucose levels, and hence, advent of these glucose meters and their adoption is facilitating screening, monitoring, and preventive care of diabetes worldwide. This is expected to drive market revenue growth during the forecast period.
Glucose meters were very helpful for diabetes patients during the lockdowns related to COVID-19 pandemic, as patients can monitor and check their blood glucose levels at home with glucose meters and then share them with medical experts in virtual clinics or online platforms. This led to rapid clinical decision-making and management of diabetes. Thus, glucose meters can help significantly in screening and monitoring blood glucose levels in diabetic population, which is expected to support revenue growth of the market.
Although technologically advanced, highly sophisticated, and minimally invasive and non-invasive glucose meters are reliable and accurate, one of the major restraints associated with them is their costs. In addition, frequent pain-related issues, mainly related to fingertip pricking cases in self-monitoring glucose devices, can limit their adoption and thus, restrict market revenue growth during the forecast period.
Some Key Highlights in the Report
-
- Wearable segment is expected to account for largest revenue share over the forecast period, due to increase in adoption of technologically advanced glucose monitoring devices and need for constant monitoring of blood glucose levels. In addition, smartwatches can collect real-time data and share it remotely, due to the development of digital glucose monitoring applications, which is expected to further increase their adoption and thus, drive revenue growth of this segment.
- Online segment is expected to account for largest revenue share over the forecast period. Growing awareness about diabetes and rise in adoption of novel, advanced devices, coupled with the availability of a wide range of glucose meters at affordable prices and discounts in different online e-commerce platforms, are driving revenue growth of this segment.
- North America is expected to account for largest revenue share in the global glucose meter market, owing to increase in prevalence of chronic diseases such as diabetes and obesity, and steady increase in diabetic-prone geriatric population in this region. In addition, presence of sophisticated advanced healthcare facilities and positive initiatives from regulatory bodies, coupled with the launch of innovative glucose monitoring devices, are supporting market revenue growth in North America.
Competitive Landscape:
The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, merger and acquisitions, collaborations, and joint ventures to gain robust footing in the market.
Top Companies Profiled in the Report:
F. Hoffmann-La Roche AG, Abbott Laboratories, Ascensia Diabetes Care, Medtronic PLC, LifeScan Inc., Nova Biomedical Corporation, OMRON Corporation, Nipro Medical Corporation, ACON Laboratories Inc., Prodigy Diabetes Care LLC, B. Braun Melsungen AG, Dexcom Inc., Ypsomed AG, Sanofi SA, Hainice Medical Inc., and Sannuo Biological Sensing Co Ltd.
To know more about the report, visit @ https://www.reportsanddata.com/report-detail/glucose-meter-market
Glucose Meter Market Segmentation:
Product Outlook (Revenue, USD Billion; 2019-2030)
- Self-Monitoring Blood Glucose System
- Continuous Glucose Monitoring System
Type Outlook (Revenue, USD Billion; 2019-2030)
- Wearable
- Non-Wearable
Regional Outlook:
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
- Latin America (Brazil, Rest of LATAM)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/95
This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.
Explore Latest Trending Research Reports By Reports and Data:
Cardiac Mapping Market Analysis, By Technology (Contact Cardiac Mapping, Non-contact Cardiac Mapping), By Application (Atrial Fibrillation, Atrial Flutter, AVNRT, Others), By End Use And By Region Forecasts To 2027
Autoimmune Disease Diagnosis Market By Product (Instruments, Consumables And Assay Kits), By Test Type (Inflammatory Markers, Routine Laboratory Tests, Autoantibodies And Immunologic Tests, Others Tests), By Disease, And By End User, And Segment Forecasts To 2027
Vitamin B12 (Cobalamin) Market By Form (Powder, Liquid, Capsule, Tablets), By Grade (Food Grade, Pharmaceutical Grade), By Sales Channel (Online Retails, Offline Retails), By End-Use Verticals (Food Industry, Nutraceuticals, Pharmaceutical, Dietary Supplements), Forecasts To 2027
Automated Insulin Delivery Systems Market Analysis, By Type (Devices, Software & Mobile App), By Applications (Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus), By End Use (Hospitals, Clinics) Forecasts To 2027
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs